Skip to main content

Sheridan John F's Form 4 filing

Tandem Diabetes Care Inc (TNDM) · filed Aug 10, 2021

Accession no.
0001438133-21-000127
Filed
Aug 10, 2021
Trade date
Aug 6-9, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.61M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sheridan John FCIK 0001365369Director, Officer (PRESIDENT & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 6, 2021Common StockMOption exerciseAcquired+746$11.06+$8,250.766,943Direct
Aug 6, 2021Common StockMOption exerciseAcquired+2,180$9.00+$19,6209,123Direct
Aug 6, 2021Common StockMOption exerciseAcquired+2,397$18.86+$45,207.4211,520Direct
Aug 6, 2021Common StockSSaleDisposed−2,523$108.03F2−$272,559.698,997Direct
Aug 6, 2021Common StockSSaleDisposed−2,800$109.39F3−$306,2926,197Direct
Aug 9, 2021Common StockMOption exerciseAcquired+9,603$18.86+$181,112.5815,800Direct
Aug 9, 2021Common StockSSaleDisposed−7,731$107.49F4−$831,005.198,069Direct
Aug 9, 2021Common StockSSaleDisposed−1,872$108.29F5−$202,718.886,197Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 6, 2021Common StockMOption exerciseAcquired+746$11.06+$8,250.760Direct
Aug 6, 2021Common StockMOption exerciseAcquired+2,180$9.00+$19,6200Direct
Aug 6, 2021Common StockMOption exerciseAcquired+2,397$18.86+$45,207.4272,603Direct
Aug 9, 2021Common StockMOption exerciseAcquired+9,603$18.86+$181,112.5863,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $108.00 to $108.13. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Referenced by the price of 1 transaction in Table I.

F3

The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $109.01 to $109.71. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Referenced by the price of 1 transaction in Table I.

F4

The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $106.96 to $107.93. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Referenced by the price of 1 transaction in Table I.

F5

The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $107.97 to $108.65. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)